Benzisothiazol-3-one-carboxylic acid amides as phospholipase inhibitors
US7595403B2 · kind B2 · utility
14Cited by
3References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 25, 2004 |
| Grant date | Sep 29, 2009 |
| Priority date | — |
| Expiry date | Mar 25, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A novel class of benzisothiazole-3(2H)-one compounds is disclosed together with the use of such compounds for inhibiting hepatic lipase and/or endothelial lipase activity for treatment, amelioration or prevention of hepatic lipase and/or endothelial lipase mediated diseases. (I)
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.